Jerusalem G, Delea TE, Martin M, et al. Quality-adjusted survival with Ribociclib plus Fulvestrant versus placebo plus Fulvestrant in postmenopausal women with HR±HER2- advanced breast cancer in the MONALEESA-3 trial. Clin Breast Cancer. 2021 Dec 20;S1526-8209(21)00369-4. doi: 10.1016/j.clbc.2021.12.008. [Epub ahead of print] | PAI - Policy Analysis Inc.

Jerusalem G, Delea TE, Martin M, et al. Quality-adjusted survival with Ribociclib plus Fulvestrant versus placebo plus Fulvestrant in postmenopausal women with HR±HER2- advanced breast cancer in the MONALEESA-3 trial. Clin Breast Cancer. 2021 Dec 20;S1526-8209(21)00369-4. doi: 10.1016/j.clbc.2021.12.008. [Epub ahead of print] | PAI - Policy Analysis Inc.